Stay updated on Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page
- Check2 days agoChange DetectedThe study page now presents the full record for a pembrolizumab and standard-therapy glioblastoma trial, including its treatment plan, eligibility criteria, outcomes, locations, and posted results. It also includes study documents and links to Mayo Clinic resources.SummaryDifference78%

- Check9 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the study page still displays a 403 error.SummaryDifference0.2%

- Check23 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check37 days agoChange DetectedThe footer revision label was updated from v3.7.0 to v3.7.1 while the page remained a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now returns a 403 Forbidden error, replacing the study record content and navigation with an error state. The added markup indicates the page is in an error condition rather than displaying the trial details.SummaryDifference23%

- Check58 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous v3.6.6 tag. This indicates an updated version of the study record.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.